Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the type 1 diabetes market grown in recent years?

The type 1 diabetes market has experienced rapid expansion and is projected to grow from $11.82 billion in 2024 to $13.62 billion in 2025, reflecting a CAGR of 15.2%. This growth is attributed to rising demand for effective treatments, increased public awareness, higher funding for drug development, and escalating global healthcare expenditures.

How is the type 1 diabetes market size expected to evolve during the forecast period?

The type 1 diabetes market is set for rapid expansion, reaching $22.7 billion in 2029 with a CAGR of 13.6%. Growth will be driven by increased awareness of early diabetes checkups, wider adoption of home-care settings, advancements in drug research, and greater awareness of nutritional products. Key trends include advanced insulin formulations, improved drug treatments, artificial pancreas systems, and personalized medicine.

Get your type 1 diabetes market report here!

https://www.thebusinessresearchcompany.com/report/type-1-diabetes-global-market-report

Which key drivers are propelling the type 1 diabetes market’s growth?

Government-led initiatives aimed at combating diabetes are projected to spur growth in the type 1 diabetes market. Such initiatives, which involve policies, plans, programs, or projects purposely devised and implemented by government entities, are designed to tackle societal issues, meet certain goals, or pioneer positive transformations in numerous societal sectors. Key governmental entities are launching a variety of programs aimed squarely at diabetes, particularly type 1 diabetes, with objectives to lower disease risk and secure affordable, equitable, quality, and comprehensive care and treatment for every patient diagnosed with the disease. For instance, JDRF Canada, which is a Canadian non-profit organization, partnered with the Canadian government in July 2023 on investing $33 million to fund 12 research projects focused on early detection, prevention, management, and treatment of diabetes. This investment is also expected to back a national research consortium for screening, bringing together professionals and individuals influenced by diabetes to further early-stage, pre-symptomatic screening of type 1 diabetes in the region. As such, the type 1 diabetes market is experiencing growth due to additional government efforts to tackle diabetes.

Key Market Driver for Type 1 Diabetes: Rising Obesity and Heart Disease Rates Spur Market Growth

What are the market segments in the type 1 diabetes industry?

The type 1 diabetes market covered in this report is segmented –

1) By Product Type: Rapid Acting Insulin Analogs, Long-Acting Insulin Analogs, Premix Insulin Analogs, Others Product Types

2) By Device: Insulin Pump, Insulin Pen, Blood Glucose Meter

3) By Application: Childrens, Adults

4) By End-User: Hospital, Research Institutes, Home Care

Subsegments:

1) By Rapid Acting Insulin Analogs: Insulin Lispro, Insulin Aspart, Insulin Glulisine

2) By Long-Acting Insulin Analogs: Insulin Detemir, Insulin Glargine, Insulin Degludec

3) By Premix Insulin Analogs: Premixed Insulin Lispro, Premixed Insulin Aspart, Premixed Insulin Glargine

4) By Other Product Types: Insulin Pumps, Continuous Glucose Monitoring Systems, Non-Insulin Medications, Combination Therapies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12872&type=smp

Which leading companies are shaping the growth of the type 1 diabetes market?

Major companies operating in the type 1 diabetes market are Johnson and Johnson Limited, Merck and Co. Inc., Sanofi-Aventis LLC., AstraZeneca PLC, Abbott Laboratories, Medtronic PLC, Eli Lilly and Co Ltd., Novo Nordisk A/S, Vertex Pharmaceuticals Incorporated, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Adaptive Biotechnologies Corporation, Xeris Pharmaceuticals Inc., MannKind Corporation, Biocon Ltd., Virta Health Corp., Bigfoot Biomedical Inc., ViaCyte Inc., Beta Bionics Inc., Adocia SA, Senseonics Holdings Inc., Zealand Pharmaceuticals A/S, Sigilon Therapeutics Inc., Provention Bio Inc.

What key trends are currently impacting the type 1 diabetes market’s development?

Leading corporations operating in the type 1 diabetes industry are concentrating on the development of technologically innovative solutions like SmartGuard technology to remain competitive in the market. This technology aids those with diabetes who may be worried about hypoglycemia or lack of awareness. For example, in March 2022, Medtronic PLC, a medical technology, services and solutions company based in Ireland, introduced the MiniMed 780G system outfitted with advanced SmartGuard technology. This product represents the next step in closed-loop insulin pump systems designed to simplify the management of type 1 diabetes. This system automates both basal insulin delivery and correction boluses every five minutes, making it easier for diabetes patients to avoid extreme highs and lows. Furthermore, this system enables patients to minimize variability and keep glucose levels within prescribed limits, facilitating a near-normal lifestyle and improved clinical results.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12872

Which geographic areas are influencing the growth of the type 1 diabetes market?

North America was the largest region in the type 1 diabetes market in 2024. The regions covered in type 1 diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Diabetes Care Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-global-market-report

Digital Diabetes Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: